{"id":4539,"date":"2026-10-07T08:24:59","date_gmt":"2026-10-07T02:54:59","guid":{"rendered":"https:\/\/www.wittytrades.com\/market-news\/sunpharma-share-price-today-2026-10-07\/"},"modified":"2026-10-07T17:27:32","modified_gmt":"2026-10-07T11:57:32","slug":"sunpharma-share-price-today-2026-10-07","status":"publish","type":"post","link":"https:\/\/www.wittytrades.com\/market-news\/sunpharma-share-price-today-2026-10-07\/","title":{"rendered":"Sun Pharmaceutical Ind L Share Price Today: Why SUNPHARMA Is Falling 1.28% | 7 October 2026"},"content":{"rendered":"<style id=\"wt-article-style-v4\">:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) { color:#30475c; font-size:16px; line-height:1.65; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::before, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) *::after { box-sizing:border-box; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-copy { font-size:16px !important; line-height:1.65 !important; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-prose .wt-copy { margin-bottom:15px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-market-date { font-size:13px !important; line-height:1.55; color:#566b80; background:#f2f6f9; border:1px solid #dde6ec; border-left:4px solid #2e7db2; border-radius:6px; padding:8px 11px; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { display:grid; grid-template-columns:repeat(6,minmax(0,1fr)); gap:7px; margin:8px 0 16px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:10px !important; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:first-child { font-size:11px !important; line-height:1.45; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child { font-size:14px !important; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px 16px; min-width:0; overflow-wrap:anywhere; margin:14px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-title { font-size:16px; font-weight:800; line-height:1.45; color:#17324d; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-date { font-size:13px; line-height:1.5; color:#566b80; margin-bottom:9px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body { font-size:16px; line-height:1.6; color:#34495d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card-body .wt-copy:last-child { margin-bottom:0 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { display:grid; grid-template-columns:repeat(2,minmax(0,1fr)); gap:12px; margin:12px 0 18px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > .wt-card { margin:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid > :only-child { grid-column:1 \/ -1; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(3,minmax(0,1fr)); margin:10px 0 12px; gap:10px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-metric { background:#fff; border:1px solid #e1e8ef; border-radius:8px; padding:10px 12px; min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-label { display:block; font-size:12px; font-weight:700; color:#566b80; line-height:1.5; margin-bottom:3px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-value { font-size:18px; font-weight:800; line-height:1.45; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-note { display:block; font-size:13px; color:#566b80; line-height:1.55; margin-top:4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source-note { margin:9px 0 4px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-source { display:inline-block; font-size:13px; line-height:1.5; margin-top:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { display:grid; grid-template-columns:2fr 1fr 1.2fr 1.2fr; gap:14px; padding:12px 0; border-bottom:1px solid #c9dbef; align-items:start; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row:last-of-type { border-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row strong { font-size:15px; line-height:1.5; display:block; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div { min-width:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds { grid-template-columns:repeat(3,minmax(0,1fr)); margin:12px 0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card { padding:12px; background:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title { font-size:14px; font-weight:700; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:14px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-brokerage { grid-template-columns:1fr; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts { display:flex; flex-wrap:wrap; gap:14px 28px; margin:7px 0 12px; padding-bottom:10px; border-bottom:1px solid #cbd8ea; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-broker-facts strong { font-size:16px; color:#17324d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list { font-size:16px !important; line-height:1.65; margin:0 0 12px; padding-left:20px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-list li { margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card { background:#f7fbff !important; border-color:#cfe1f2 !important; border-left-color:#2e7db2 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-card-title { color:#1f4d70; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-takeaways .wt-list { margin-bottom:0; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card { background:#f5fbfd !important; border-color:#c9d9e7 !important; border-left:5px solid #1f7b92 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-title { color:#174c5d; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-likely-reason .wt-card-body > strong { display:block; margin-bottom:6px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:18px 19px; margin:22px 0; border-radius:13px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:19px; font-weight:800; line-height:1.4; margin-bottom:7px; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow { background:linear-gradient(135deg,#ffe873,#ffd64a); border:1px solid #e3b600; box-shadow:0 8px 18px rgba(59,48,0,.09); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-title { color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-yellow .wt-cta-copy { color:#27364b !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark { background:#10233f; box-shadow:0 9px 22px rgba(16,35,63,.18); }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-title { color:#fff !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-copy { color:#dce6f1 !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-copy { font-size:16px !important; line-height:1.6; margin:0 0 12px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-button { display:inline-block; background:#10233f; color:#fff !important; padding:10px 17px; border-radius:7px; text-decoration:none !important; font-size:15px; font-weight:800; line-height:1.5; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-dark .wt-cta-button { background:#ffe36e; color:#10233f !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-faq h3 { color:#173b58 !important; font-size:17px !important; line-height:1.45; margin:18px 0 6px !important; }\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) > p:last-child { font-size:13px; line-height:1.55; color:#606b78; border-top:1px solid #e1e7ef; padding-top:13px; margin-top:16px; }\n@media (max-width:960px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(3,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:1.7fr 1fr 1.2fr 1.2fr; gap:10px; }\n}\n@media (max-width:650px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid { grid-template-columns:1fr; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-metrics { grid-template-columns:repeat(2,minmax(0,1fr)); }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-card { padding:14px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row { grid-template-columns:repeat(2,minmax(0,1fr)); gap:10px 14px; padding:12px 0; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-person, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-insider-row > div:last-child { grid-column:1 \/ -1; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta { padding:17px 15px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-cta-title { font-size:18px; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div { padding:9px !important; }\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-title, :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-grid-funds .wt-card-body { font-size:15px; }\n}\n@media (max-width:420px) {\n :is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip { grid-template-columns:repeat(2,minmax(0,1fr)); }\n}<\/p>\n<p>:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div {border:1px solid #dde6ee;border-radius:8px;background:#f9fbfd;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) .wt-price-strip > div > div:last-child {font-weight:800;color:#17324d;}\n:is(.wt-article-v4,.single-post .entry-content .wt-article-v4) h2 {font-size:24px !important;line-height:1.35 !important;margin:28px 0 14px !important;color:#173b58;}\n<\/style>\n<div class=\"wt-article-v4\" data-witty-phase=\"live\" data-article-version=\"4\">\n<p class=\"wt-market-date\"><strong>NSE: SUNPHARMA<\/strong> \u00b7 7 October 2026<\/p>\n<div class=\"wt-price-strip\">\n<div>\n<div>Price<\/div>\n<div>\u20b91,781.00<\/div>\n<\/div>\n<div>\n<div>Change<\/div>\n<div>-1.28%<\/div>\n<\/div>\n<div>\n<div>High \/ Low<\/div>\n<div>\u20b91,804.10 \/ \u20b91,772.20<\/div>\n<\/div>\n<div>\n<div>Prev. Close<\/div>\n<div>\u20b91,804.10<\/div>\n<\/div>\n<div>\n<div>Volume<\/div>\n<div>11.37 lakh<\/div>\n<\/div>\n<div>\n<div>Price as of<\/div>\n<div>7 October 2026 \u00b7 03:15 PM IST<\/div>\n<\/div>\n<\/div>\n<div class=\"wt-takeaways\">\n<div class=\"wt-card\" data-card=\"research\" style=\"background:#f4f8fd;border:1px solid #cbd8ea;border-left:4px solid #466fa5;border-radius:10px\">\n<div class=\"wt-card-title\">Key Takeaways<\/div>\n<div class=\"wt-card-body\">\n<ul class=\"wt-list\">\n<li>Sun Pharmaceutical Industries Ltd shares fell 1.28% to close at \u20b91,781.0 on October 7, 2026. The stock moved within a day&#x27;s range of \u20b91,772.2 to \u20b91,804.1 after opening at \u20b91,793.6 with a gap-down of 0.58%.<\/li>\n<li>Sun Pharmaceutical Industries announced the creation of the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai, supported by a $2.5 million endowment. Dr. Mark G. Lebwohl was installed as the inaugural professor to fund academic leadership and research in dermatologic care. As a major player in US dermatology prescriptions, this initiative reinforces the company&#x27;s long-term academic partnerships and brand presence.<\/li>\n<li>Trading volume was 0.77 times the 20-day average daily volume.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<h2>Why is Sun Pharmaceutical Ind L share price falling on 7 October 2026?<\/h2>\n<div class=\"wt-prose\">\n<p class=\"wt-copy\">Sun Pharmaceutical Industries Ltd shares fell 1.28% to close at \u20b91,781.0 on October 7, 2026. The stock moved within a day&#x27;s range of \u20b91,772.2 to \u20b91,804.1 after opening at \u20b91,793.6 with a gap-down of 0.58%.<\/p>\n<p class=\"wt-copy\">The broader market also faced downward pressure, with the Nifty declining by 0.76% and the Nifty Pharma sector benchmark slipping 0.43%. Sun Pharma&#x27;s price action ran slightly weaker than the sectoral trend. Over the preceding five trading days, the stock has retreated 1.96%, extending a 20-day return loss of 4.50%.<\/p>\n<p class=\"wt-copy\">Company disclosures from October 6, 2026, highlighted that Sun Pharma established a $2.5 million endowed professorship in dermatology at the Icahn School of Medicine at Mount Sinai, directed by Dr. Mark G. Lebwohl. While this reflects ongoing specialty expansion and brand building in the US dermatology market, this corporate development is strategic in nature and provides long-term context rather than serving as a direct catalyst for today&#x27;s intraday share price movement.<\/p>\n<p class=\"wt-copy\">11.37 lakh shares traded by 7 October 2026 \u00b7 03:15 PM IST. This compares with a 20-day average daily volume of 14.77 lakh shares (0.77 times). The five-day average daily volume was 14.97 lakh shares. Separately, the NSE report for 6 October 2026 showed 8.86 lakh shares delivered, representing 59.93% of that day\u2019s traded volume. The same report recorded 67,783 trades.<\/p>\n<\/div>\n<div class=\"wt-likely-reason\">\n<div class=\"wt-card\" data-card=\"research\" style=\"background:#f4f8fd;border:1px solid #cbd8ea;border-left:4px solid #466fa5;border-radius:10px\">\n<div class=\"wt-card-title\">Likely Reason<\/div>\n<div class=\"wt-card-body\"><strong>Sector weakness and lower-volume profit-taking<\/strong><\/p>\n<p class=\"wt-copy\">The 1.28% decline aligns with broader market and sectoral softening led by the Nifty&#x27;s 0.76% drop. Trading volume remained below normal averages at 0.77% of the 20-day volume, alongside a total cash delivery volume of 885,883 shares representing a 59.93% delivery percentage, indicating no single confirmed operational catalyst drove the session.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<aside class=\"wt-cta wt-cta-yellow\">\n<div class=\"wt-cta-title\">Research the Market \u2014 Not Just the Headline<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Latest Company Developments<\/h2>\n<div class=\"wt-grid wt-grid-news\">\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Establishment of Endowed Professorship at Mount Sinai<\/div>\n<div class=\"wt-card-date\">6 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Sun Pharmaceutical Industries announced the creation of the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai, supported by a $2.5 million endowment. Dr. Mark G. Lebwohl was installed as the inaugural professor to fund academic leadership and research in dermatologic care. As a major player in US dermatology prescriptions, this initiative reinforces the company&#x27;s long-term academic partnerships and brand presence.<\/p>\n<p class=\"wt-copy\">It strengthens Sun Pharma&#x27;s strategic positioning and institutional relationships within the North American specialty dermatology sector.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNSEC_06102026182517_SEintimationPRforMSP.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">LEQSELVI Two-Year Data Presented at EADV Congress<\/div>\n<div class=\"wt-card-date\">1 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">The company announced featured presentations at the European Academy of Dermatology and Venereology (EADV) Congress 2026 regarding LEQSELVI (deuruxolitinib). Data from an open-label extension study demonstrated sustained efficacy, durability of scalp hair regrowth, and a consistent safety profile over two years in adults with severe alopecia areata. These findings add to the clinical evidence supporting the company&#x27;s high-growth global innovative medicines portfolio.<\/p>\n<p class=\"wt-copy\">Demonstrating long-term safety and durable efficacy supports the commercial rollout and adoption of key specialty assets in regulated international markets.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNPHARMA123_01102026174411_SEIntimationPR_1Oct2026.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Press Release<\/div>\n<div class=\"wt-card-date\">6 October 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNSEC_06102026182517_SEintimationPRforMSP.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Earnings \/ operating update<\/div>\n<div class=\"wt-card-date\">29 September 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">&#x27;Completion and Result of Postal Ballot dated 25 August 2026&#x27;.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNSEC_28092026200828_SEIntimationforVR.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"news\" style=\"background:#fff;border:1px solid #dce5eb;border-left:4px solid #2e7db2;border-radius:10px\">\n<div class=\"wt-card-title\">Company update<\/div>\n<div class=\"wt-card-date\">7 August 2026<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Receipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group.<\/p>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNHARSH_06082026203354_SEIntimationNOCforReclassification.pdf\" rel=\"noopener\">Original source \u2192<\/a><\/div>\n<\/div>\n<\/div>\n<h2>Ownership &amp; Transaction Activity<\/h2>\n<div class=\"wt-grid wt-grid-ownership\">\n<div class=\"wt-card\" data-card=\"ownership\" style=\"background:#fff8e8;border:1px solid #ecd39e;border-left:4px solid #cc922c;border-radius:10px\">\n<div class=\"wt-card-title\">Shareholding<\/div>\n<div class=\"wt-card-date\">As of 30 June 2026<\/div>\n<div class=\"wt-card-body\">\n<div class=\"wt-grid wt-grid-metrics\">\n<div class=\"wt-metric\">\n<div class=\"wt-label\">Promoter holding<\/div>\n<div class=\"wt-value\">54.48%<\/div>\n<div class=\"wt-note\">54.48% on 31 March 2026<\/div>\n<\/div>\n<div class=\"wt-metric\">\n<div class=\"wt-label\">FII\/FPI<\/div>\n<div class=\"wt-value\">14.53%<\/div>\n<div class=\"wt-note\">15.93% on 31 March 2026<\/div>\n<\/div>\n<div class=\"wt-metric\">\n<div class=\"wt-label\">Institutional holding<\/div>\n<div class=\"wt-value\">36.71%<\/div>\n<div class=\"wt-note\">37.04% on 31 March 2026<\/div>\n<\/div>\n<\/div>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1694893_17072026122439_WEB.xml\" rel=\"noopener\">NSE shareholding filing \u2192<\/a><\/div>\n<\/div>\n<\/div>\n<h2>Mutual Fund Holdings<\/h2>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Mutual-fund ownership<\/div>\n<div class=\"wt-card-body\">\n<p class=\"wt-copy\">Mutual funds held 12.84% on 30 June 2026. This compares with 11.96% on 31 March 2026, a change of +0.88 percentage points.<\/p>\n<p class=\"wt-copy\">The filing reported 49 MF\/UTI holders.<\/p>\n<div class=\"wt-grid wt-grid-funds\">\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Icici Prudential Value Fund<\/div>\n<div class=\"wt-card-date\">30 June 2026<\/div>\n<div class=\"wt-card-body\">8.92 crore shares \u00b7 3.72%<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Sbi Nifty 50 Etf<\/div>\n<div class=\"wt-card-date\">30 June 2026<\/div>\n<div class=\"wt-card-body\">5.67 crore shares \u00b7 2.36%<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"funds\" style=\"background:#f7f9fc;border:1px solid #d5e0ea;border-left:4px solid #6a849c;border-radius:10px\">\n<div class=\"wt-card-title\">Nippon Life India Trustee Ltd-A\/C Nippon India Large Cap Fund<\/div>\n<div class=\"wt-card-date\">30 June 2026<\/div>\n<div class=\"wt-card-body\">3.31 crore shares \u00b7 1.38%<\/div>\n<\/div>\n<\/div>\n<div class=\"wt-note wt-source-note\">These are quarterly holdings, rather than purchases or sales on the article date.<\/div>\n<p><a class=\"wt-source\" href=\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1694893_17072026122439_WEB.xml\" rel=\"noopener\">NSE shareholding filing \u2192<\/a><\/div>\n<\/div>\n<h2>Historical Bulk \/ Block Deals<\/h2>\n<div class=\"wt-grid wt-grid-cards\">\n<div class=\"wt-card\" data-card=\"deals\" style=\"background:#fff8f2;border:1px solid #ead4c0;border-left:4px solid #b17640;border-radius:10px\">\n<div class=\"wt-card-title\">The Mtbj Ltd. As Trst For Govrnmnt Pension Invstmnt Fund Mutb400045794<\/div>\n<div class=\"wt-card-date\">24 June 2026<\/div>\n<div class=\"wt-card-body\">Buy \u00b7 1.54 lakh shares \u00b7 \u20b91,868.00<\/p>\n<div class=\"wt-note wt-source-note\">Public market-data page<\/div>\n<\/div>\n<\/div>\n<div class=\"wt-card\" data-card=\"deals\" style=\"background:#fff8f2;border:1px solid #ead4c0;border-left:4px solid #b17640;border-radius:10px\">\n<div class=\"wt-card-title\">The Mtbj Ltd. As Trst For Govrnmnt Pension Invstmnt Fund Mtbj400045828<\/div>\n<div class=\"wt-card-date\">24 June 2026<\/div>\n<div class=\"wt-card-body\">Sell \u00b7 1.54 lakh shares \u00b7 \u20b91,868.00<\/p>\n<div class=\"wt-note wt-source-note\">Public market-data page<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h2>What to Watch Next<\/h2>\n<ul class=\"wt-list\">\n<li>Progress and voting outcome of the ongoing Postal Ballot ending on October 31, 2026, concerning ESOP 2026 and enabling financial limits.<\/li>\n<li>Commercial update and prescription trends for LEQSELVI following long-term safety data presentations at the EADV Congress.<\/li>\n<li>Sectoral performance of the Nifty Pharma index and broader market direction.<\/li>\n<li>Delivery percentage trends against the 20-day average volume of 1,136,762 shares to gauge institutional participation.<\/li>\n<\/ul>\n<h2>Other Dated Coverage<\/h2>\n<ul class=\"wt-list\">\n<li><a href=\"https:\/\/www.wittytrades.com\/market-news\/sunpharma-share-price-today-2026-09-30\/\">Why Sun Pharma Shares Fell 2.60% Today Amid Pharma Sector Weakness | 30 September 2026 \u2014 30 September 2026<\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.wittytrades.com\/market-news\/tag\/sunpharma\/\">More Sun Pharmaceutical Ind L news and dated analysis \u2192<\/a><\/p>\n<aside class=\"wt-cta wt-cta-dark\">\n<div class=\"wt-cta-title\">Looking for Research-Backed Market Opportunities?<\/div>\n<p class=\"wt-cta-copy\">Explore WittyTrades research across market segments.<\/p>\n<p><a class=\"wt-cta-button\" href=\"https:\/\/www.wittytrades.com\/Segments.html\">Explore WittyTrades Research \u2192<\/a><\/aside>\n<h2>Frequently Asked Questions<\/h2>\n<div class=\"wt-faq\">\n<h3>What is the latest Sun Pharmaceutical Ind L company news?<\/h3>\n<p class=\"wt-copy\">Sun Pharmaceutical Industries announced the creation of the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai, supported by a $2.5 million endowment. Dr. Mark G. Lebwohl was installed as the inaugural professor to fund academic leadership and research in dermatologic care. As a major player in US dermatology prescriptions, this initiative reinforces the company&#x27;s long-term academic partnerships and brand presence.<\/p>\n<h3>How strong was Sun Pharmaceutical Ind L\u2019s trading volume?<\/h3>\n<p class=\"wt-copy\">11.37 lakh shares traded, 0.77 times the 20-day average daily volume. The price and volume data are dated 7 October 2026 \u00b7 03:15 PM IST.<\/p>\n<h3>Do the mutual-fund figures show buying today?<\/h3>\n<p class=\"wt-copy\">They show holdings on 30 June 2026. Quarterly holdings do not identify purchases made on the article date.<\/p>\n<\/div>\n<p><strong>Research &amp; analysis:<\/strong> <a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">WittyTrades Research Desk<\/a><br \/><strong>Reviewed by:<\/strong> <a href=\"https:\/\/www.wittytrades.com\/About_Us.html\">Mohanish Sanghavi \u2014 SEBI Registered Research Analyst<\/a><\/p>\n<p>Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.<\/p>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"NewsArticle\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/sunpharma-share-price-today-2026-10-07\/#article\", \"mainEntityOfPage\": {\"@type\": \"WebPage\", \"@id\": \"https:\/\/www.wittytrades.com\/market-news\/sunpharma-share-price-today-2026-10-07\/\"}, \"headline\": \"Sun Pharmaceutical Ind L Share Price Today: Why SUNPHARMA Is Falling 1.28% | 7 October 2026\", \"description\": \"Sun Pharmaceutical Ind L share price fell 1.28% to \u20b91,781.00 today. See why SUNPHARMA is falling, volume context, company developments and what to watch next.\", \"datePublished\": \"2026-10-07T02:54:59Z\", \"dateModified\": \"2026-10-07T17:27:21.914248+05:30\", \"author\": {\"@type\": \"Organization\", \"name\": \"WittyTrades Research Desk\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"reviewedBy\": {\"@type\": \"Person\", \"name\": \"Mohanish Sanghavi\", \"jobTitle\": \"SEBI Registered Research Analyst\", \"url\": \"https:\/\/www.wittytrades.com\/About_Us.html\"}, \"publisher\": {\"@type\": \"Organization\", \"name\": \"WittyTrades\", \"url\": \"https:\/\/www.wittytrades.com\/\"}, \"inLanguage\": \"en-IN\", \"image\": [\"https:\/\/www.wittytrades.com\/market-news\/wp-content\/uploads\/2026\/10\/sunpharma-company-news-2026-10-07.jpg\"]}<\/script><!-- wt-article-record:{\"news_events\":[{\"title\":\"Press Release\",\"summary\":\"Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care\",\"source\":\"NSE\",\"published\":\"06-Oct-2026 18:25:27\",\"source_type\":\"official filing\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNSEC_06102026182517_SEintimationPRforMSP.pdf\",\"disclosure_text\":\"Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B\/1, Western Express Highway, Goregaon (E), Mumbai \u2013 400 063, Maharashtra, INDIA. Tel.: (91-22) 4324 4324 Fax: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 Registered Office: SPARC, Tandalja, Vadodara \u2013 390 012, Gujarat, INDIA. Reaching People. Touching Lives. 06 October 2026 National Stock Exchange of India Limited Scrip Symbol: SUNPHARMA BSE Limited Scrip Code: 524715 In timation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 \u2013 Press Release Enclosed herewith is a copy of the press release titled \u201cSun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care ,\u201d which shall be released after this intimation. Fo r Sun Pharmaceutical Industries Limited ( Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B\/1, Western Express Highway, Goregaon (E), Mumbai \u2013 400 063, Maharashtra, INDIA. Tel.: (91-22) 4324 4324 Fax: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 FOR IMMEDIATE RELEASE Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care \u2022 Endowment will fund academic leadership in dermatology in perpetuity, supporting research, education and mentorship \u2022 Mark G. Lebwohl, MD, installed as inaugural professor in recognition of his leadership and contributions to dermatologic care MUMBAI, India and PRINCETON, N.J., October 6, 2026 \u2013 Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and\/or affiliated companies, \u201cSun Pharma\u201d)) today announced the establishment of the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai. Mark G. Lebwohl, M.D., will be installed as the inaugural professor at a ceremony held today at Hatch Auditorium at The Mount Sinai Hospital in New York. Supported by a $2.5 million endowment from Sun Pharma, the Sun Professorship will fund academic leadership in dermatology in perpetuity, beginning with Dr. Lebwohl as its inaugural incumbent. Based within the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, the professorship will advance research and training, helping translate emerging knowledge into better care and prepare future leaders in the field. As the second-largest pharmaceutical dermatology company in the U.S. by prescription volume, Sun Pharma is committed to advancing patient care through scientific innovation, education and partnerships. \u201cAt Sun Pharma, we believe meaningful progress in dermatology care requires supporting the people and institutions advancing the field today and in the future,\u201d said Ahmad Naim, M.D., Senior Vice President and Chief Medical Officer, North America. \u201cThe establishment of this professorship reflects our long-term commitment to fostering the academic leadership needed to pursue new ideas and strengthen care for generations to come.\u201d Dr. Lebwohl serves as Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai and Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology. Internationally recognized for his contributions to psoriasis research and treatment, Dr. Lebwohl has helped advance understanding of inflammatory skin diseases and played a key role in shaping standards of care that have improved patient outcomes worldwide. His work as a clinician, investigator and mentor has influenced the future generation of dermatologists and helped accelerate innovation across the field. Dr. Lebwohl is Chairman Emeritus of the Medical Board of the National Psoriasis Foundation and served as President of the American Academy of Dermatology from 2015 to 2016. \\\"Mount Sinai and Sun Pharma share a longstanding commitment to advancing care for patients with serious skin diseases. This professorship reflects a shared belief that investing in scientific excellence and academic leadership ultimately leads to better outcomes for patients around the world,\u201d said Emma Guttman, M.D., Ph.D., Waldman Professor and System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai. \\\"Dermatology has undergone a remarkable transformation over the past several decades, and continued progress depends on supporting the next generation of clinicians, investigators, and innovators. Sun Pharma's generosity will help sustain that momentum and strengthen the future of our specialty.\\\" \u201cDr. Lebwohl\u2019s influence on dermatology can be seen not only in his contributions to research and clinical care, but also in the many physicians and investigators he has guided throughout his career,\u201d said Eric J. Nestler, M.D., Ph.D., Dean of the Icahn School of Medicine at Mount Sinai and Chief Scientific Officer of the Mount Sinai Health System. \u201cThe Sun Professorship is a fitting recognition of his impact on the field, and we are grateful to Sun Pharma for making this enduring academic honor possible.\u201d \u201cI am deeply honored to be named the inaugural holder of the Sun Professorship in Dermatology,\u201d said Dr. Lebwohl. \u201cThe greatest value of this professorship is the opportunity it creates to pursue important questions, support promising investigators and help turn scientific advances into better care for patients.\u201d About Sun Pharmaceutical Industries Limited (CIN - L24230GJ1993PLC019050) Sun Pharma is a leading global pharmaceutical company with a strong presence in Innovative Medicines, Generics and Consumer Healthcare products. Guided by its vision of reaching people and touching lives, Sun Pharma works to support patients throughout their healthcare journey and deliver medicines that address needs across a range of conditions. It is the largest pharmaceutical company in India and is a leading generic company in the U.S. as well as Global Emerging Markets. The company is a recognized leader in dermatology and is committed to advancing care through scientific innovation, education and partnerships that help improve patient outcomes. Sun\u2019s high growth Global Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and oncodermatology and accounts for about 22% of company sales. The company\u2019s vertically integrated operations deliver high- quality medicines, trusted by physicians and consumers in over 100 countries. Its manufacturing facilities are spread across five continents. Sun Pharma is proud of its multi-cultural workforce drawn from over 50 nations. For further information, please visit www.sunpharma.com and follow us on LinkedIn & X. Sun Pharma Contacts: Investors: Dr. Abhishek Sharma Tel: +91 22 4324 4324, Ext 2929 Tel Direct: +91 22 4324 2929 Mobile: +91 98196 86016 Email: abhi.sharma@sunpharma.com India Media: Gaurav Chugh Tel: +91 22 4324 4324, Ext 5373 Tel Direct: +91 22 4324 5373 Mobile: +91 98104 71414 Email: gaurav.chugh@sunpharma.com U.S. Media: Rob Perry, Head of North America Corporate Communications Mobile: +1 609 921 4269 Email: robert.perry@sunpharma.com\"},{\"summary\":\"'Completion and Result of Postal Ballot dated 25 August 2026'.\",\"category\":\"Updates\",\"date\":\"28-Sep-2026 20:09:05\",\"source\":\"NSE filing\",\"industry\":\"Pharmaceuticals\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNSEC_28092026200828_SEIntimationforVR.pdf\",\"headline\":\"Earnings \/ operating update\",\"impact\":\"Earnings updates are directly relevant to valuation. Revenue growth, margins, profit growth and management guidance are the key items to compare with expectations.\",\"importance_score\":5,\"completeness_score\":3},{\"summary\":\"Receipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group.\",\"category\":\"General Updates\",\"date\":\"06-Aug-2026 20:34:28\",\"source\":\"NSE filing\",\"industry\":\"Pharmaceuticals\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNHARSH_06082026203354_SEIntimationNOCforReclassification.pdf\",\"headline\":\"Company update\",\"impact\":\"This is a recent company development worth monitoring. It should not automatically be treated as the sole cause of today's price move.\",\"importance_score\":2,\"completeness_score\":5}],\"recent_news\":[{\"summary\":\"'Completion and Result of Postal Ballot dated 25 August 2026'.\",\"category\":\"Updates\",\"date\":\"28-Sep-2026 20:09:05\",\"source\":\"NSE filing\",\"industry\":\"Pharmaceuticals\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNSEC_28092026200828_SEIntimationforVR.pdf\",\"headline\":\"Earnings \/ operating update\",\"impact\":\"Earnings updates are directly relevant to valuation. Revenue growth, margins, profit growth and management guidance are the key items to compare with expectations.\",\"importance_score\":5,\"completeness_score\":3},{\"summary\":\"Receipt of No-objection letters from the Stock Exchanges for Reclassification of Promoter Group.\",\"category\":\"General Updates\",\"date\":\"06-Aug-2026 20:34:28\",\"source\":\"NSE filing\",\"industry\":\"Pharmaceuticals\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/SUNHARSH_06082026203354_SEIntimationNOCforReclassification.pdf\",\"headline\":\"Company update\",\"impact\":\"This is a recent company development worth monitoring. It should not automatically be treated as the sole cause of today's price move.\",\"importance_score\":2,\"completeness_score\":5}],\"shareholding_snapshot\":{\"promoter_pct\":54.48,\"public_pct\":45.52,\"fii_pct\":14.53,\"dii_pct\":22.18,\"mf_pct\":12.84,\"institutional_pct\":36.71,\"noninst_pct\":8.81,\"mf_scheme_count\":49,\"pledged_shares\":null,\"pledged_pct_of_promoter\":null,\"mf_holders\":[{\"name\":\"Icici Prudential Value Fund\",\"shares\":89198583,\"pct\":3.72},{\"name\":\"Sbi Nifty 50 Etf\",\"shares\":56689578,\"pct\":2.36},{\"name\":\"Nippon Life India Trustee Ltd-A\/C Nippon India Large Cap Fund\",\"shares\":33125559,\"pct\":1.38}],\"period\":\"30-JUN-2026\",\"submission_date\":\"17-JUL-2026\",\"source\":\"NSE shareholding pattern XBRL\",\"source_url\":\"https:\/\/nsearchives.nseindia.com\/corporate\/xbrl\/SHP_1694893_17072026122439_WEB.xml\",\"previous_period\":\"31-MAR-2026\",\"previous_promoter_pct\":54.48,\"previous_fii_pct\":15.93,\"previous_dii_pct\":21.11,\"previous_mf_pct\":11.96,\"previous_institutional_pct\":37.04,\"previous_mf_scheme_count\":47,\"previous_pledged_pct_of_promoter\":null,\"previous_pledged_shares\":null},\"bulk_block_deals\":[{\"deal_type\":\"Block\",\"date\":\"24 Jun, 2026\",\"party\":\"The Mtbj Ltd. As Trst For Govrnmnt Pension Invstmnt Fund Mutb400045794\",\"side\":\"Buy\",\"quantity\":\"154424\",\"price\":\"1,868\",\"source\":\"Public market-data page\",\"value\":\"\u20b928.85 Cr\"},{\"deal_type\":\"Block\",\"date\":\"24 Jun, 2026\",\"party\":\"The Mtbj Ltd. As Trst For Govrnmnt Pension Invstmnt Fund Mtbj400045828\",\"side\":\"Sell\",\"quantity\":\"154424\",\"price\":\"1,868\",\"source\":\"Public market-data page\",\"value\":\"\u20b928.85 Cr\"}]} --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sun Pharmaceutical Ind L share price fell 1.28% to \u20b91,781.00 today. See why SUNPHARMA is falling, volume context, company developments and what to watch next.<\/p>\n","protected":false},"author":1,"featured_media":4538,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_witty_seo_title":"Sun Pharmaceutical Ind L Share Price Today: Why SUNPHARMA Is Falling 1.28% | 7 October 2026","_witty_meta_description":"Sun Pharmaceutical Ind L share price fell 1.28% to \u20b91,781.00 today. See why SUNPHARMA is falling, volume context, company developments and what to watch next.","_witty_primary_phrase":"Sun Pharmaceutical Ind L share price today","_witty_reason_label":"Sector weakness and lower-volume profit-taking","_witty_reason_confidence":"low","footnotes":"","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_aioseop_title":"","_aioseop_description":""},"categories":[3,4],"tags":[199],"class_list":["post-4539","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-movers","category-stocks-in-news","tag-sunpharma"],"_links":{"self":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/4539","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/comments?post=4539"}],"version-history":[{"count":7,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/4539\/revisions"}],"predecessor-version":[{"id":5216,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/posts\/4539\/revisions\/5216"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media\/4538"}],"wp:attachment":[{"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/media?parent=4539"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/categories?post=4539"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wittytrades.com\/market-news\/wp-json\/wp\/v2\/tags?post=4539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}